Sironi S, Belloni C, Taccagni L, Del Maschio A
Radiologia Diagnostica, Università, Milano.
Radiol Med. 1990 Sep;80(3):314-20.
In patients with cervical carcinoma the selection of the optimal therapy depends on the precise preoperative assessment of the extent of disease. Currently, decisions regarding the management of these patients are made on the basis of clinical (FIGO) staging that has 50% mean error rate. To investigate the value of MR imaging in staging patients with invasive cervical cancer, we performed 25 MR examinations on 23 patients with histologic diagnosis of cervical cancer. All patients were clinically considered as having stage IB or IIB disease and underwent radical hysterectomy, providing specimens for pathologic correlation. The overall accuracy of MR imaging in staging cervical carcinoma (stage IB-IIB) was 78.1%. MR imaging seems to be the most reliable preoperative modality for staging invasive cervical cancer.
对于宫颈癌患者，最佳治疗方案的选择取决于术前对疾病范围的精确评估。目前，这些患者的治疗决策是基于临床（国际妇产科联盟[FIGO]）分期做出的，而该分期的平均错误率为50%。为了研究磁共振成像（MR成像）在浸润性宫颈癌患者分期中的价值，我们对23例经组织学诊断为宫颈癌的患者进行了25次MR检查。所有患者临床均被认为患有IB期或IIB期疾病，并接受了根治性子宫切除术，提供标本用于病理对照。MR成像对宫颈癌（IB-IIB期）分期的总体准确率为78.1%。MR成像似乎是术前对浸润性宫颈癌进行分期最可靠的检查方法。
